Brokers are filling vacant retail spaces with corporate parties, personal events and an assortment of fan-focused pop-ups. They hope the crowds will want to return later for a fun night, a nice dinner or even office or residential space.
The partnership will connect undergraduate students and degree programs from the IU Indianapolis campus with opportunities at Lilly, such as finance, human resources and information technology.
Wong’s appointment comes just a few weeks after BioCrossroads released a report warning that Indiana’s life-science sector is starting to lag the nation in growth and market share and will require a focused effort to stay competitive.
Thirty-four Indiana companies landed $287 million in venture capital in 2023 to help finance a wide array of technologies, from medical isotopes to stem-cell therapies, according to BioCrossroads, an Indianapolis-based group that promotes and invests in the state’s life sciences sector and tracks the funding.
Lilly said it was working closely with the FDA and the “situation does not affect the quality, safety or supply of any current or planned Lilly products in the marketplace.”
Universities, hospitals, museums, theaters, dance companies and other not-for-profits in Indiana pulled in a total of $348.7 million from 79 gifts of $1 million or more from individuals, family foundations and bequests, according to IBJ’s latest survey.
State Rep. Cindy Ledbetter introduced the bill this month, saying utilities are moving too fast to retire and replace generating capacity that might be needed as demand for electricity grows.
The bill would would prohibit health insurers from requiring prior authorization for routine medical services, federally approved prescription drugs, emergency health care and other services.
The conservative Braun and the liberal Sanders might have more in common that meets the eye, with a growing list of issues they have both supported.
Indianapolis-based DecisionRx uses technology to recommend medication decisions to physicians and pharmacists based on genetic profiles, existing medication regimes and contraindications.
In addition, the Ricks Family Foundation says it will match up to an additional $2.5 million in donations from individuals, foundations and corporations.
Indiana’s pharmaceutical and medical device sectors, long touted as major contributors to the state’s economy, are starting to lag the nation in growth and market share and will require a focused effort to stay competitive, according to a new report released Monday.
Paragon Healthcare Inc., based in suburban Dallas, serves more than 35,000 patients with a broad range of acute and chronic conditions at more than 40 ambulatory infusion centers across eight southern and western states, as well as in patients’ homes.
Lilly called the lawsuit “baseless” and said PDL BioPharma “has no plausible claim to royalties” for donanemab, which is expected to be approved by the FDA this quarter.
David Ricks led Eli Lilly and Co. to milestone after milestone in 2023, with a slew of product launches for diseases from obesity to inflammatory bowel disease. And when Lilly wasn’t scoring wins in the laboratory, it was issuing a series of head-turning announcements,
It was a busy year for the Indiana life sciences community, with a flurry of billion-dollar deals, major announcements, and a few setbacks. Here we present the top 10 stories of 2023—the good, the bad and the ugly—about an industry that is often hailed as a key driver of Indiana’s economy.
RayzeBio is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment.
History: The Chevrolet Silverado, the second-most-popular pickup truck in America last year, is made at General Motors Co.’s Fort Wayne Assembly Plant. The 3-million-square-foot facility was built in 1986 and today employs nearly 4,000 people. GM has invested $1.2 billion in the plant, which recently celebrated manufacturing its 10 millionth truck. In June, GM announced […]
Fauna Bio, based in the San Francisco area, said Thursday it will give Lilly access to its AI platform, called Convergence, to support preclinical drug discovery efforts in obesity.
The investment in Sudo Biosciences, a three-year-old Carmel biotech, is one of the largest in recent years for an Indiana-based science startup, a signal that investors are attracted by its work on a class of drugs to treat autoimmune and inflammatory diseases.
